December 4-6, 2018

Boston, MA

View Full Agenda

View event brochure for the OV Summit 2018 with a detailed agenda, workshop details, expert speaker line-up, 18+ focused case studies and attendance breakdown.

Thumbnail for the brochure
Grant McFadden

Grant McFadden, Center Director & Professor, Biodesign Center for Immunotherapy, ASU

Masataka Suzuki

Masataka Suzuki, Assistant Professor, Baylor College of Medicine

Brad Nelson

Brad Nelson, Director, Deeley Research Centre BC Cancer Agency

Frank Tufaro

Frank Tufaro, CEO, DNAtrix

Antonio Chiocca

Antonio Chiocca, Professor, Harvard Medical School

Faris Farassati

Faris Farassati, Associate Professor, University of Kansas Medical School

Angelica Loskog

Angelica Loskog, CEO, Lokon Pharma

Rachel Altura

Rachel Altura, Senior Medical Director,  Merck & Co.

Christophe Queva

Christophe Queva, Chief Scientific Officer, Oncorus

Steven Potts

Steven Potts, CEO, OncoMyx

Robert Coffin

Robert Coffin, CEO, Replimmune

Anna Cascante

Anna Cascante, Head of R&D, Sagetis Biotech

Magnus Jaderberg

Magnus Jaderberg, CMO, Targovax

Min Liang

Min Liang, CSO, TOT biopharma

Jose Manual Otero

José Manuel Otero, Vice President, CMC & Manufacturing, Turnstone Biologics

Michael Paglia

Michael Paglia,
Vice President, CMC, Operations Oncorus

OLYMPUS DIGITAL CAMERA

Stephen Thorne, Chief Scientific Officer, Western Oncolytics

William Jia

William Jia, Chief Scientific Officer, Virogen Biotech

Jason DeVoss

Jason DeVoss, Senior Scientist, Amgen

Firelli Alfonso

Firelli Alfonso
Senior Director, BioTherapeutics & Vaccines Outsourcing, Pfizer

Stephen Russell

Stephen Russell
Chief Executive Officer
Vyriad

Scott Dewire

Scott DeWire
Global Head of BD&L Cancer Immunology,
Immune Modulation and Biotherapeutics, 

Boehringer Ingelheim

KwilasPhoto

Anna Kwilas
Product CMC Reviewer
U.S. Food and Drug Administration